MAS Stock Analysis: Masco | NYSE
Building Products & Equipment | NYSE, USA | Market Cap: 15.281m USD | 12M Return: 16.7% | Charts, Fundamentals & Technical Analysis
Avg Turnover: 178M
EPS Trend: 79.8%
Qual. Beats: 1
Rev. Trend: -94.2%
Qual. Beats: 1
Warnings
No concerns identified
Tailwinds
Seasonality 10.5 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Masco Corporation is a U.S.-based manufacturer of home improvement and building products, operating through two core segments: Plumbing Products and Decorative Architectural Products. The Plumbing Products segment manufactures faucets, showerheads, valves, bath and shower enclosures, spas, water filtration systems, and PEX tubing under a wide portfolio of brands including DELTA, BRIZO, HANSGROHE, KRAUS, HOT SPRING, and BRASSCRAFT, with products sold both under company-owned labels and private label arrangements.
The Decorative Architectural Products segment produces paints, primers, stains, and specialty coatings (under the BEHR and KILZ brands), as well as cabinet hardware, functional hardware, and bath/shower accessories under LIBERTY and FRANKLIN BRASS. Products reach customers through home centers, mass merchandisers, online retailers, wholesalers, distributors, plumbing contractors, remodelers, and OEMs, giving the company exposure to both new construction and home repair and remodeling demand.
Founded in 1929 and headquartered in Livonia, Michigan, Masco sits within the GICS Industrials sector and Building Products sub-industry. The building products industry is closely tied to residential housing starts, renovation cycles, and consumer spending on home improvement, with major brands typically distributed through large home improvement retailers that act as key channel partners.
- Higher mortgage rates slow existing home sales and remodeling demand
- Behr paint pricing power offsets raw material cost inflation
- Plumbing segment margins hold up despite softer new construction volumes
| Net Income: 837.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.18 > 0.02 and ΔFCF/TA 1.51 > 1.0 |
| NWC/Revenue: 16.17% < 20% (prev 15.51%; Δ 0.66% < -1%) |
| CFO/TA 0.21 > 3% & CFO 1.10b > Net Income 837.0m |
| Net Debt (3.14b) to EBITDA (1.43b): 2.20 < 3 |
| Current Ratio: 1.75 > 1.5 & < 3 |
| Outstanding Shares: last quarter (202.9m) vs 12m ago -4.76% < -2% |
| Gross Margin: 35.41% > 18% (prev 36.23%; Δ -0.82% > 0.5%) |
| Asset Turnover: 148.5% > 50% (prev 150.8%; Δ -2.30% > 0%) |
| Interest Coverage Ratio: 12.61 > 6 (EBIT TTM 1.27b / Interest Expense TTM 101.0m) |
| A: 0.24 (Total Current Assets 2.90b - Total Current Liabilities 1.65b) / Total Assets 5.23b |
| B: -0.14 (Retained Earnings -722.0m / Total Assets 5.23b) |
| C: 0.25 (EBIT TTM 1.27b / Avg Total Assets 5.17b) |
| D: -0.05 (Book Value of Equity -242.0m / Total Liabilities 5.21b) |
| Altman-Z'' = 2.71 = A |
| DSRI: 1.05 (Receivables 1.32b/1.26b, Revenue 7.68b/7.70b) |
| GMI: 1.02 (GM 36.23% / 35.41%) |
| AQI: 1.20 (AQ_t 0.22 / AQ_t-1 0.18) |
| SGI: 1.00 (Revenue 7.68b / 7.70b) |
| TATA: -0.05 (NI 837.0m - CFO 1.10b) / TA 5.23b) |
| Beneish M = -2.85 (Cap -4..+1) = A |
As of July 10, 2026, the stock is trading at USD 76.64 with a total of 1,009,846 shares traded. Over the past week, the price has changed by -6.12%, over one month by +5.93%, over three months by +21.42% and over the past year by +16.72%.
Current recommended Stop Loss: 73.40 (which is 4.2% or 1.3 ATR below the current price).
Masco has received a consensus analysts rating of 3.67. Therefore, it is recommended to hold MAS.
- StrongBuy: 7
- Buy: 1
- Hold: 12
- Sell: 1
- StrongSell: 0
| Analysts Target Price | 81 | 5.7% |
P/E Trailing = 19.6244
P/E Forward = 19.4932
P/S = 1.99
P/B = 160.2462
P/EG = 2.0506
Revenue TTM = 7.68b USD
EBIT TTM = 1.27b USD
EBITDA TTM = 1.43b USD
Long Term Debt = 2.94b USD (from longTermDebt, last quarter)
Short Term Debt = 129.0m USD (from shortTermDebt, last quarter)
Debt = 3.53b USD (from shortLongTermDebtTotal, last quarter) + Leases 228.0m
Net Debt = 3.14b USD (calculated: Debt 3.53b - CCE 388.0m)
Enterprise Value = 18.4b USD (15.3b + Debt 3.53b - CCE 388.0m)
Interest Coverage Ratio = 12.61 (Ebit TTM 1.27b / Interest Expense TTM 101.0m)
EV/FCF = 19.54x (Enterprise Value 18.4b / FCF TTM 943.0m)
FCF Yield = 5.12% (FCF TTM 943.0m / Enterprise Value 18.4b)
FCF Margin = 12.28% (FCF TTM 943.0m / Revenue TTM 7.68b)
Net Margin = 10.90% (Net Income TTM 837.0m / Revenue TTM 7.68b)
Gross Margin = 35.41% ((Revenue TTM 7.68b - Cost of Revenue TTM 4.96b) / Revenue TTM)
Gross Margin QoQ = 35.77% (prev 33.69%)
Tobins Q-Ratio = 3.52 (Enterprise Value 18.4b / Total Assets 5.23b)
Interest Expense / Debt = 2.86% (Interest Expense 101.0m / Debt 3.53b)
Taxrate = 24.32% (285.0m / 1.17b)
NOPAT = 964.2m (EBIT 1.27b * (1 - 24.32%))
Current Ratio = 1.75 (Total Current Assets 2.90b / Total Current Liabilities 1.65b)
Debt / Equity = -14.59 (negative equity) (Debt 3.53b / totalStockholderEquity, last quarter -242.0m)
Debt / EBITDA = 2.20 (Net Debt 3.14b / EBITDA 1.43b)
Debt / FCF = 3.33 (Net Debt 3.14b / FCF TTM 943.0m)
Total Stockholder Equity = 37.5m (last 4 quarters mean from totalStockholderEquity)
RoA = 16.19% (Net Income 837.0m / Total Assets 5.23b)
RoE = 2.23k% (out of range, set to none) (Net Income TTM 837.0m / Total Stockholder Equity 37.5m)
RoCE = 42.72% (EBIT 1.27b / Capital Employed (Equity 37.5m + L.T.Debt 2.94b))
RoIC = 29.00% (NOPAT 964.2m / Invested Capital 3.33b)
WACC = 8.34% (E(15.3b)/V(18.8b) * Re(9.77%) + D(3.53b)/V(18.8b) * Rd(2.86%) * (1-Tc(0.24)))
Discount Rate = 9.77% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -98.88 | Cagr: -4.31%
[DCF] Terminal Value 76.87% ; FCFF base≈903.0m ; Y1≈995.5m ; Y5≈1.27b
[DCF] Fair Price = 80.61 (EV 19.4b - Net Debt 3.14b = Equity 16.3b / Shares 201.7m; r=8.35% [WACC [floored]]; 5y FCF grow 11.86% → 2.50% )
EPS Correlation: 79.84 | EPS CAGR: 3.39% | SUE: 1.87 | # QB: 1
Revenue Correlation: -94.17 | Revenue CAGR: -2.55% | SUE: 2.99 | # QB: 1
EPS current Quarter (2026-06-30): EPS=1.31 | Chg30d=-0.16% | Revisions=-25% | Analysts=20
EPS next Quarter (2026-09-30): EPS=1.06 | Chg30d=+0.25% | Revisions=+25% | Analysts=20
EPS current Year (2026-12-31): EPS=4.27 | Chg30d=+0.01% | Revisions=+87% | GrowthEPS=+7.9% | GrowthRev=+2.7%
EPS next Year (2027-12-31): EPS=4.70 | Chg30d=+0.02% | Revisions=+84% | GrowthEPS=+10.2% | GrowthRev=+3.1%
[Analyst] Revisions Ratio: +88% (up=37, down=1)